Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
NRX Pharmaceuticals (NRXP) Stock Price & Analysis
262 Followers
NRXP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.21 - $12.00
Previous Close$3.02
Volume768.98K
Average Volume (3M)206.48K
Market Cap
$28.90M
Enterprise Value$24.31M
Total Cash (Recent Filing)$4.59M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.7
Beta0.99
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.08
Shares Outstanding9,569,978
10 Day Avg. Volume293,045
30 Day Avg. Volume206,477
Standard Deviation0.29
R-Squared0.09
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)-3.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NRX Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NRXP FAQ
What was NRX Pharmaceuticals’s price range in the past 12 months?
NRX Pharmaceuticals lowest stock price was $2.21 and its highest was $12.00 in the past 12 months.
What is NRX Pharmaceuticals’s market cap?
Currently, no data Available
When is NRX Pharmaceuticals’s upcoming earnings report date?
NRX Pharmaceuticals’s upcoming earnings report date is May 14, 2024 which is in 25 days.
How were NRX Pharmaceuticals’s earnings last quarter?
NRX Pharmaceuticals released its earnings results on Apr 01, 2024. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.8 by $0.3.
Is NRX Pharmaceuticals overvalued?
According to Wall Street analysts NRX Pharmaceuticals’s price is currently Overvalued.
Does NRX Pharmaceuticals pay dividends?
NRX Pharmaceuticals does not currently pay dividends.
What is NRX Pharmaceuticals’s EPS estimate?
NRX Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NRX Pharmaceuticals have?
NRX Pharmaceuticals has 9,569,978 shares outstanding.
What happened to NRX Pharmaceuticals’s price movement after its last earnings report?
NRX Pharmaceuticals reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.8. Following the earnings report the stock price went up 11.229%.
Which hedge fund is a major shareholder of NRX Pharmaceuticals?
Among the largest hedge funds holding NRX Pharmaceuticals’s share is Owl Creek Asset Management, L.P.. It holds NRX Pharmaceuticals’s shares valued at N/A.
---
NRX Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 5.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 7.0%
Last 30 Days ▼ 7.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-34.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-71.66%
Trailing 12-Months
Company Description
NRX Pharmaceuticals
Big Rock Partners Acquisition Corp. is a blank check company, which was formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses or entities. It focuses on identifying a prospective target business in the senior housing and care industry in the United States. The firm's care segments are commonly divided into four categories: Independent Living; Assisted Living; Memory Care and Nursing Care. The company was founded on September 18, 2017 and is headquartered in Delray Beach, FL.
---
NRXP Earnings Call
Q4 2024
0:00 / 0:00
---
NRXP Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering NRXP
1 Year
1 Year Success Rate
1/8 ratings generated profit
1 Year Average Return
-34.16%
reiterated a buy rating 3 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -34.16% per trade.
---